Log in
Enquire now
‌

US Patent 10562891 Quinazolinones as PARP14 inhibitors

Patent 10562891 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10562891 Quinazolinones as PARP14 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.